5-amino-1mq dosing guidelines Peptide Guide: Oral Protocol, Reconstitution & Safety (2026) 5-Amino-1-MQ Treatment Protocol – Provider's

These products are not drugs, foods, cosmetics, or dietary supplements, have not been evaluated by the FDA, and are not intended for human or animal use

Oral versions such as capsules or troches are more convenient, but absorption through the digestive tract is far less consistent, so the amount that actually reaches circulation can vary widely

GLP-1 receptor agonism promotes insulin secretion in a glucose-dependent manner, reduces appetite, and slows gastric emptying

The study also highlighted AOD9604s influence on fat metabolism and energy expenditure, and its interaction with 3-adrenergic pathways [2]

Is AOD 9604 safe for patients with diabetes or insulin resistance

Researchers study it for fat-cell shrinkage, higher NAD+ levels, and metabolic support without affecting appetite